Buzz
In 2016, the opioid epidemic claimed the lives of 59,000 Americans. It is estimated that around 2.6 million individuals in the US are dependent on prescription opioids, with nearly twice as many using heroin. To date, approximately 77 million Americans have been affected by this crisis in some form.
The root of the issue lies in the medical and pharmaceutical sectors, compounded by the influx of inexpensive heroin from Mexico and US-controlled Afghanistan, dealers' access to potent synthetic opioids like fentanyl, and widespread despair across many regions of the country. Below are ten key points about the opioid crisis in the United States.
10. Profiting from Pain
In May 2007, the manufacturers of the prescription opioid OxyContin admitted to deceiving doctors, patients, and regulators about the drug's dangers. Purdue Pharma settled for over $600 million after deliberately concealing the drug's potential for addiction and misuse. This settlement addressed both civil and criminal allegations against the pharmaceutical company.
Introduced in 1996, OxyContin underwent the most aggressive promotional push of any narcotic painkiller. Within a few years, its annual sales soared to $1 billion. The drug's supposed safety relied on its time-release feature, but users soon found that crushing the pills delivered a heroin-like high. Internal records showed that Purdue Pharma anticipated resistance to OxyContin. The company targeted general practitioners for prescriptions, despite their limited expertise in pain management and identifying patient abuse. Sales representatives provided doctors with misleading charts about the drug's risks.
9. The Link to Afghanistan
Before the US/NATO invasion of Afghanistan in 2001, the US had 189,000 heroin users. By 2016, that number surged to 4.5 million. Between 2000 and 2001, the Taliban, collaborating with the UN, outlawed opium production. Just before the invasion, they reduced cultivation from 82,000 to 7,600 hectares. By 2016, cultivation had exploded to 224,000 hectares, coinciding with a US-led, taxpayer-funded $8.5 billion effort to eradicate Afghanistan's opium poppies.
During the 1960s and 1970s, the CIA partnered with opium producers in the Golden Triangle to combat Communism. In the 1980s, they smuggled Nicaraguan cocaine into Los Angeles to fund contras. Today, the US has been in Afghanistan for 16 years, marking the longest conflict in the nation's history—creating both opportunity and motive to engage in the profitable opium trade.
8. Lifesaving Overdose Reversal
Naloxone is a critical lifesaver. This opioid antagonist can immediately counteract an overdose by attaching to the brain's opioid receptors. While generic versions of naloxone have existed for years, it is now produced by six companies. Five offer intravenous forms, and one produces a nasal spray known as Narcan. Due to its ease of use, Narcan is increasingly favored by police and healthcare providers.
Local law enforcement and first responders have mixed opinions about opioid antidotes. The sheriff of Clermont County, Ohio, views equipping deputies with the nasal spray as a moral obligation. However, just 80 kilometers (50 mi) away in Butler County, law enforcement refuses to carry the overdose antidote. The sheriff there argues that administering it is better left to medical professionals and poses risks to officers. Critics also argue that naloxone enables continued drug use.
7. The Kratom Controversy
In October 2016, federal authorities reversed their decision to outlaw a plant that could potentially help address the opioid epidemic. Earlier, in August, the DEA had classified the Southeast Asian kratom plant as a Schedule I drug, placing it in the same category as LSD and heroin. The DEA attributed 15 deaths to kratom between 2014 and 2016, though 14 of those cases involved other substances.
Kratom, often brewed as a tea, contains mitragynine and 7-hydroxymitragynine, compounds that stimulate the brain's opioid receptors. In small amounts, it offers mild stimulation, while larger doses produce sedation and pain relief. Kratom may serve as a less addictive substitute for opioids, delivering similar effects without the life-threatening respiratory suppression linked to heroin. Thailand (then Siam) outlawed kratom in 1943, fearing it would undercut opium tax revenues.
6. The Unseen Sufferers
Children are among the most overlooked victims of the US opioid epidemic. Abandoned by addicted parents, orphaned by overdoses, or taken into protective custody, tens of thousands of children have been torn from their families. The Department of Health and Human Services reported that 92,000 children entered foster care in 2016 due to the opioid crisis—the highest number in over three decades. The last comparable surge in displaced children occurred during the 1980s crack epidemic. This time, opioids are to blame.
In 2016, Georgia, Indiana, and West Virginia saw the largest spikes in drug-related foster care placements. Vanderburgh County, Indiana, with a population of 179,000, recorded more children of drug users entering the system than major cities like Los Angeles, Miami, or Seattle. Additionally, the number of babies born addicted to heroin has risen sharply. These infants suffer from neonatal abstinence syndrome, enduring symptoms such as piercing cries, sleeplessness, and tremors as they endure painful withdrawal.
5. Trump’s Strong Rhetoric
In October 2017, President Trump labeled the opioid crisis a “public health emergency.” However, with no allocated budget to address the nationwide issue, his administration has left state and local governments to handle the burden. Despite his campaign pledges, the first year of the Trump presidency concluded with little more than bold statements.
Furthermore, the GOP tax bill could lead to severe reductions in Medicare, Medicaid, and other programs that provide essential funding for local efforts to tackle the crisis. “Listing a few supportive measures [ . . . ] does not constitute a strategy for addressing a public health emergency,” says Andrew Kolodny, an opioid policy expert at Brandeis University. “We need a detailed plan and a funding request in the billions to establish a comprehensive treatment system.”
4. The Fentanyl Epidemic
In October, the Centers for Disease Control revealed that fentanyl was involved in 50 percent of opioid overdose deaths in 2016. This synthetic opioid, legally restricted to medical use, claimed at least 20,000 lives that year. Fentanyl, 50 times more potent than heroin, has become the preferred opioid in regions like New England. The DEA reports that much of the fentanyl in New England is produced in Mexico using Chinese ingredients. Cartels capitalized on the region's history of prescription painkiller abuse, first introducing low-quality heroin at 18 percent purity. By 2015, they marketed a product called “China White,” claiming higher potency and purity, but it was simply heroin laced with fentanyl. Some dealers may not even know their product contains fentanyl, increasing the risk of overdose due to its strength and lack of awareness.
3. The Opioid Vaccine Initiative
To combat the opioid crisis, researchers are exploring vaccines designed to block the drugs' euphoric effects while easing withdrawal symptoms. These vaccines would produce antibodies that attach to opioid molecules, preventing them from reaching the brain. If successful, users would no longer experience the high associated with opioids.
However, all opioid vaccine attempts since the 1970s have failed, as they couldn't produce enough antibodies to effectively protect humans. Despite this, progress is being made. A team at the Scripps Research Institute has developed a vaccine that neutralizes heroin's effects in rhesus monkeys. The US Army is also experimenting with a combined opioid and HIV vaccine. Additionally, drugs targeting withdrawal symptoms, like lofexidine, show promise. Lofexidine is already approved in the UK and is undergoing FDA review in the US.
2. A Root Cause
The opioid crisis in the US may signal a more profound issue. A recent study revealed that in certain rural California counties, the premature death rate among white individuals aged 25 to 35 has more than doubled. Funded by the California Endowment’s Building Healthy Communities initiative, the study found that opioid overdoses accounted for only 33 percent of the surge. Alcohol-related illnesses and suicides also played significant roles.
The rise in self-inflicted deaths suggests that rural white Californians may be succumbing to “deaths of despair.” As the economy transitions from manufacturing to information services, this demographic feels marginalized, leading to substance abuse and suicide. A similar trend was observed in Russia during the fall of communism. This pervasive sense of hopelessness has been spreading through America’s rural areas for decades. Some believe the shift to a global economy, combined with insufficient social support, is fueling this fatal despair.
1. The Staggering Toll
In 2015, the White House Council of Economic Advisors estimated the true cost of the US opioid epidemic at $504 billion—six times higher than previous estimates and equivalent to 2.8 percent of the nation’s GDP that year. This figure includes healthcare expenses, criminal justice costs, and lost productivity. The crisis continues to worsen, with overdose deaths doubling over the past decade. However, past underreporting of prescription drug-related deaths may have contributed to the sharp increase.
The National Institutes of Health allocates $116 million annually to research aimed at tackling opioid addiction. Dr. Francis Collins of the NIH has emphasized that funding must quadruple or quintuple to match the crisis's escalating severity. The NIH's objectives include creating pharmaceutical solutions for addiction, developing potent antidotes to counteract fentanyl, and discovering nonaddictive alternatives for pain management.
